Summary
Updated Aug 30, 2026
Paul Andrew Moore is Chief Scientific Officer of Zymeworks Inc. (ZYME). 2 SEC Form 4 filings on record, most recently on 13 January 2026. Most recent open-market trade: sold $217K of ZYME on 13 January 2026. Lifetime open-market sales: $721K.
Recent Transactions
6Every recent SEC Form 4 transaction Paul Andrew Moore has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Paul Andrew Moore go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul Andrew Moore files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kenneth Galbraith - $3.34M of ZYME open-market activity in the last 12 months
- Jeffrey T. L. Smith - $476K of ZYME open-market activity in the last 12 months
- Mark Hollywood - $139K of ZYME open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Paul Andrew Moore?
Paul Andrew Moore is a corporate insider, tracked as Chief Scientific Officer of Zymeworks Inc. (ZYME). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Paul Andrew Moore last file a Form 4?
The most recent primary Form 4 on record is dated 13 January 2026, one of 2 filings going back to 2026.
Has Paul Andrew Moore been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($721K) across all tracked filings.
Where can I see all of Paul Andrew Moore's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Paul Andrew Moore and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial